RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine Investment will help fund pre-market approval for use in spine, trauma and orthopaedics Biocomposites, CEO, Michael Harris will join Renovos Biologics Board of Directors KEELE, England, July…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.